Search Results - "van Meel, J.C.A."

Pharmacological characterization of the novel nonpeptide angiotensin II receptor antagonist, BIBR 277 by Wienen, W., Hauel, N., Meel, J.C.A., Narr, B., Ries, U., Entzeroth, M.

“…1 The pharmacological profile of BIBR 277, 4′‐[(1,4′‐dimethyl‐2′‐propyl[2,6′‐bi‐1H‐benzimidazol]‐1′‐yl)methyl]‐[1,1′‐biphenyl]‐2‐carboxylic acid, a novel,…”
Get full text

158 BIBF1120 a novel, small molecule triple angiokinase inhibitor: profiling as a clinical candidate for cancer therapy by Hilberg, F., Tontsch-Grunt, U., Colbatzky, F., Heckel, A., Lotz, R., van Meel, J.C.A., Roth, G.J.

Get full text

Antihypertensive activity of the novel, nonpeptide angiotensin II receptor antagonists BIBS 39 and BIBS 222 in conscious renal hypertensive rats by Zhang, J, Van Meel, J C, Van Zwieten, P A

“…BIBS 39 and BIBS 222 are novel, nonpeptide angiotensin II receptor antagonists with a benzimidazole structure. These compounds, in contrast to the angiotensin…”
Get more information

The effect of selective alpha1- and alpha2- adrenoceptor stimulation on intraocular pressure in the conscious rabbit by Innemee, H.C, Jonge, A. de, Meel, J.C.A. van, Timmermans, P.B.M.W.M, Zwieten, P.A. van (Amsterdam Univ. (Netherlands). Dept. of Pharmacy. Div. of Pharmacotherapy)

Get full text